{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:14:00Z","timestamp":1789913640033,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.vaccine.2008.05.095","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T10:52:57Z","timestamp":1221043977000},"page":"5888-5895","source":"Crossref","is-referenced-by-count":143,"title":["Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein"],"prefix":"10.1016","volume":"26","author":[{"given":"Ana Paula","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00edriam Maria Silva","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Ant\u00f4nio Ferraz","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilene Suzan Marques","family":"Michalick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo\u00edsa","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Norma","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner","family":"Luiz Tafuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela de Melo","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius","family":"Hermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane de Freitas","family":"Abrantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Tostes","family":"Gazzinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.05.095_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2008.05.095_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0031182003004578","article-title":"Leishmania donovani complex: genotyping with the ribosomal internal transcribed spacer and the mini-exon","volume":"128","author":"Mauricio","year":"2004","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2008.05.095_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.05.095_bib4","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0020-7519(00)00136-3","article-title":"The leishmaniases as emerging and reemerging zoonoses","volume":"30","author":"Ashford","year":"2000","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.05.095_bib6","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/MCB.14.5.2975","article-title":"Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene","volume":"14","author":"Charest","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-2958.2001.02286.x","article-title":"Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection","volume":"39","author":"Zhang","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib8","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1073\/pnas.94.16.8807","article-title":"Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein A2","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.05.095_bib9","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/S0264-410X(01)00023-8","article-title":"Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response","volume":"19","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.095_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.095_bib11","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.05.095_bib12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.micinf.2007.05.012","article-title":"Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections","volume":"9","author":"Zanin","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2008.05.095_bib13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1128\/CDLI.4.5.530-535.1997","article-title":"Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis","volume":"4","author":"Ghedin","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0732-8893(02)00410-8","article-title":"Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen","volume":"43","author":"Carvalho","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2008.05.095_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/CVI.00420-06","article-title":"Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs","volume":"14","author":"Porrozzi","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib16","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1128\/IAI.02032-05","article-title":"Leishmania chagasi T-cell antigens identified through a double library screen","volume":"74","author":"Martins","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.05.095_bib17","series-title":"Essentials of veterinary haematology","author":"Jain","year":"1993"},{"key":"10.1016\/j.vaccine.2008.05.095_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1023090929302","article-title":"Distribution and relationship between clinical and histopathological parameters in canine leishmaniasis","volume":"18","author":"Amusategui","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib19","series-title":"Clinical biochemistry of domestic animals","author":"Kaneko","year":"1997"},{"key":"10.1016\/j.vaccine.2008.05.095_bib20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0035-9203(88)90510-X","article-title":"Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment","volume":"82","author":"Mancianti","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.05.095_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.actatropica.2004.04.007","article-title":"Canine visceral leishmaniasis: a histopathological study of lymph nodes","volume":"92","author":"Lima","year":"2004","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2008.05.095_bib22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4269\/ajtmh.1993.49.364","article-title":"Isolation and characterization of a repetitive DNA sequence from Leishmania infantum: development of a visceral leishmaniasis polymerase chain reaction","volume":"49","author":"Piarroux","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"21","key":"10.1016\/j.vaccine.2008.05.095_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(02)00444-9","article-title":"Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis","volume":"22","author":"Santos","year":"2002","journal-title":"Vaccine"},{"issue":"54","key":"10.1016\/j.vaccine.2008.05.095_bib24","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1021\/jf060169h","article-title":"Quillaja saponin can modulate ovalbumin-induced IgE allergic responses through regulation of Th1\/Th2 balance in a murine model","volume":"3","author":"Katayama","year":"2006","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.vaccine.2008.05.095_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1471-4922(02)02347-4","article-title":"Canine leishmaniasis: epidemiological risk and the experimental model","volume":"18","author":"Moreno","year":"2002","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vetpar.2006.01.011","article-title":"Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis","volume":"137","author":"Francino","year":"2006","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.2001.64.119","article-title":"Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies","volume":"64","author":"Travi","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.05.095_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijpara.2006.11.007","article-title":"A long term experimental study of canine visceral leishmaniasis","volume":"37","author":"Rodriguez-Cortes","year":"2007","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4269\/ajtmh.2004.70.618","article-title":"Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi","volume":"70","author":"Sanchez","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.05.095_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.rvsc.2005.09.011","article-title":"Parasite density and impaired biochemical\/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis","volume":"81","author":"Reis","year":"2006","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2008.05.095_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.05.095_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-4017(97)00208-2","article-title":"The immunology of canine leishmaniosis: strong evidence for a developing disease spectrum from asymptomatic dogs","volume":"76","author":"Cabral","year":"1998","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3024.2006.00840.x","article-title":"Immunology of canine leishmaniasis","volume":"28","author":"Barbieri","year":"2006","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vetimm.2006.10.001","article-title":"Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi","volume":"115","author":"Lage","year":"2007","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vetpar.2006.06.028","article-title":"Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs","volume":"142","author":"Manna","year":"2006","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3024.1995.tb00914.x","article-title":"Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites","volume":"17","author":"Deplazes","year":"1995","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-2427(97)00072-X","article-title":"Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs","volume":"59","author":"Bourdoiseau","year":"1997","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4017(00)00446-5","article-title":"Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment","volume":"96","author":"Solano-Gallego","year":"2001","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.05.095_bib39","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.tvjl.2006.11.006","article-title":"Canine visceral leishmaniasis: relationships between clinical status, humoral immune response, haematology and Lutzomyia (Lutzomyia) longipalpis infectivity","volume":"174","author":"da Costa-Val","year":"2007","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2008.05.095_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetpar.2007.03.004","article-title":"Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, to Lutzomyia longipalpis phlebotomine sand flies","volume":"147","author":"Michalsky","year":"2007","journal-title":"Vet Parasitol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T05:34:56Z","timestamp":1588916096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08011572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":40,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0264410X08011572"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.095","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}